Market Performance
AbbVie Inc. (NYSE:ABBV) reached a new 52-week high of $261.63 during today's trading session.
The Healthcare stock has traded year-to-date and 0.3% over the past week. The previous 52-week high was $261.63.
Market Performance AbbVie Inc. (NYSE:ABBV) reached a new 52-week high of $261.63 during today's trading session. The Healthcare stock has traded year-to-date and 0.3% over the…

AbbVie Inc. (NYSE:ABBV) reached a new 52-week high of $261.63 during today's trading session.
The Healthcare stock has traded year-to-date and 0.3% over the past week. The previous 52-week high was $261.63.
AbbVie Inc. has a market capitalization of $410.1B. The stock's 52-week low was $190.75.
Reaching a 52-week high often signals strong momentum and investor confidence in AbbVie Inc.. Stocks at new highs can continue trending higher as breakout buying kicks in, though they also face increased selling pressure from profit-taking. The key question is whether fundamentals support the elevated valuation.
AbbVie Inc. currently trades at $258.64, positioning the stock at the 96th percentile of its 52-week range ($190.75 — $261.63). This range context helps investors assess whether the stock is trading near support, resistance, or fair value relative to its recent history.
Related Tools: View ABBV Stock Page
Price movements can be driven by earnings, analyst actions, or sector trends. Check the latest on our ABBV news page.
See full price history and interactive charts on our ABBV chart page.
Current market data
NYSE · ABBV
$250.82
Down: -$1.33 · -0.53%
Live quote updated
Keep reading